BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Jun 5, 2026; 17(2): 118848
Published online Jun 5, 2026. doi: 10.4292/wjgpt.v17.i2.118848
Table 1 Demographic and clinical variables of 36 patients randomized into group 1 and group 2, n (%)
Variable
Group 1 (control or no traction; n = 18)
Group 2 (study group with dynamic traction on the laparostomy bag; n = 18)
P value
Mean age (years ± SD)43.78 ± 11.6641.61 ± 15.670.6410
Male:female ratio1:14:51.000
Primary laparostomy creation2 (11.11)5 (27.78)1.000
Needing re-application of laparostomy 3 (16.67)6 (33.33)1.000
Creation of stoma13 (72.2)10 (55.6)1.000
Comorbidity
Hypertension1 (5.56)1 (5.56)1.000
Diabetes mellitus7 (38.89)6 (33.33)
Chronic liver disease1 (5.56)0
Pulmonary disease1 (5.56)1 (5.56)
Etiology
Tuberculosis6 (33.33)6 (33.33)0.76
Enteric fever7 (38.89)5 (27.78)
Trauma1 (5.56)3 (16.67)
Ruptured liver abscess2 (11.11)3 (16.67)
Others2 (11.11)1 (5.56)
Investigations
Abnormal liver function tests 8 (44.4)10 (55.6)0.74
Mean INR1.65 ± 0.5681.66 ± 0.4860.915
Mean serum creatinine (mg/dL ± SD)1.61 ± 0.6241.61 ± 0.6241.00
Mean serum albumin (g/dL ± SD)2.80 ± 0.5702.76 ± 0.5340.829
Viral markers positive (HBsAg, HIV, HCV)2 (11.11)1 (5.56)1.00
Mean blood transfusion units per patient1.671.831.000
SOFA score > 9 at admission 4 (22.2)4 (22.2)1.000
Mean initial fascial gap (cm ± SD)14.2 ± 2.315.1 ± 2.11.000


Write to the Help Desk